Lupin Limited has informed the Exchange regarding a press release dated September 24, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Bictegravir, Emtricitabine, andTenofovir Alafenamide Tablets".
Lupin Limited has informed the Exchange regarding a press release dated September 24, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Bictegravir, Emtricitabine, andTenofovir Alafenamide Tablets".